At City of Hope®, you'll find comprehensive cancer care under one roof. Our clinical programs and departments provide a wide array of services to deliver an accurate diagnosis and personalized treatment plan. A multidisciplinary team of physicians, practitioners and support staff provide integrative cancer treatment, tailored to each patient's unique diagnosis, needs and goals. Learn more about the many diseases we treat and the therapies and innovations we put to work.
Breast cancer is a disease in which breast tissue cells start growing abnormally and uncontrollably. As a National Cancer Institute-designated comprehensive cancer center, City of Hope is internationally lauded for advancing the field of breast cancer through groundbreaking, evidence-based research, on-site innovative clinical trials, leading-edge treatment and premier patient care.
We are specialists for surgical and nonsurgical management of cancers of the lower gastrointestinal tract, including colon cancer, as well as a variety of benign conditions of the anus, colon and rectum. U.S. News & World Report has ranked City of Hope Duarte as a “High Performing Hospital” for colon cancer surgery.
City of Hope Duarte Cancer Center is a national leader in treating leukemia, with a world-renowned bone marrow and stem cell transplant program. Our team of experts can precisely diagnose leukemia, classify its subtype, identify its severity, and find the best treatments for fighting the disease. City of Hope leukemia clinicians and researchers collaborate extensively to develop and evaluate new therapies for better survival and quality-of-life outcomes.
City of Hope takes a team-based approach to your health and offers access to advanced procedures that are not available at other centers. Our thoracic specialists are among the best when it comes to minimally invasive, lung-sparing surgery for lung cancer, and we perform one of the largest volumes of thoracic surgeries in California.
Lymphomas are the most common type of blood cancer, broadly categorized as either Hodgkin or non-Hodgkin disease. All lymphoma subtypes combined are the seventh most common cancer in the United States. Getting treated for lymphoma at City of Hope gives you access to unparalleled treatment options and exceptional care from experts in all subtypes of the disease, from rare and unusual to complex and chronic.
Myeloma is not a common cancer type, accounting for less than 1% of new cancer cases and 10% of blood and bone marrow cancers. Myeloma develops when plasma cells — infection-fighting blood cells in the immune system — become abnormal and grow and divide uncontrollably to become tumors. Our Myeloma Program brings together expert clinicians and scientists with extensive experience in not just diagnosing and treating myeloma but also researching new and innovative therapies for the disease.
City of Hope is a nationally recognized leader in the research and treatment of urologic cancers. With superior outcomes and one of the largest prostate cancer programs in the western United States, City of Hope is the best choice for prostate cancer surveillance, treatment, survivorship and improved quality of life.